ImmunoCAP Phadiatop
Taiwan·Risk Class 2·MD·PHADIA AB·Registered Nov 17, 2015 – Nov 17, 2025Expired- Analysis ID
- b2ecf2cdafffe6bdb78234b896ea9805
- License Form
- Ministry of Health Medical Device Import No. 027906
- Customs Code
- DHA05602790609
- Manufacturer
- PHADIA AB
- Manufacturer Country
- Sweden
- Authorized Representative
- PHADIA TAIWAN INC.
- Intended Use
- This product qualitatively and semi-quantitatively grades the specific IgE of inhaled allergens in human serum or plasma. Its purpose is for clinical laboratory in vitro diagnosis, combined with other clinical evidence as an auxiliary clinical diagnosis method for IgE allergic diseases. This product is used with Fadia 100, Fadia 250 or Fadia 1000 instruments for testing.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C5510 Immunoglobulins A, G, M, D and E Immunoassay System
- Import Information
- Imported from abroad
- Registration Date
- Nov 17, 2015
- Expiry Date
- Nov 17, 2025
Top companies providing products similar to "ImmunoCAP Phadiatop"
Recently registered similar products
Access comprehensive regulatory information for ImmunoCAP Phadiatop in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b2ecf2cdafffe6bdb78234b896ea9805 and manufactured by PHADIA AB. The authorized representative in Taiwan is PHADIA TAIWAN INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including PHADIA AB, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.